apomorphine has been researched along with Anxiety in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (17.86) | 18.7374 |
| 1990's | 2 (7.14) | 18.2507 |
| 2000's | 11 (39.29) | 29.6817 |
| 2010's | 10 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonuti, R; Morato, S; Rico, JL | 1 |
| Du, CX; Guo, Y; Liu, J; Lv, SX; Zhang, J; Zhang, QJ | 1 |
| Aguiar, JC; Guimarães, FS; Lisboa, SF; Magesto, AC; Resstel, LB | 1 |
| Farmer, M; Goldstein, I; Yoon, H | 1 |
| Abdullahi, OI; Abolarin, M; Iniaghe, LO; Magaji, MG; Magaji, RA | 1 |
| Abramov, U; Innos, J; Kõks, S; Kurrikoff, K; Lasner, H; Luuk, H; Plaas, M; Raud, S; Sütt, S; Vasar, E | 1 |
| Koch, M; Wegener, N | 1 |
| Becker, A; Berek, I; Grecksch, G; Härtl, A; Höllt, V; Schröder, H | 1 |
| Hosseini, SS; Rezayof, A; Zarrindast, MR | 1 |
| de Araújo, FY; de Moraes, MO; de Oliveira, GV; de Sousa, FC; Leal, LK; Macêdo, DS; Moura, BA; Silva, MI; Vasconcelos, SM; Viana, GS | 1 |
| Asadi, F; Bahrami, F; Naghdi-Sedeh, N; Nasehi, M; Sahraei, H; Zarrindast, MR | 1 |
| Ahmadi, S; Mahboobi, S; Sadat-Shirazi, MS; Zarrindast, MR | 1 |
| Iezhitsa, IN; Kharitonova, MV; Kravchenko, MS; Spasov, AA | 1 |
| Andel, M; Brunerova, L; Horacek, J; Koprivova, H; Potockova, J; Rehula, M | 1 |
| Gewirtz, JC; Radke, AK | 1 |
| van den Buuse, M | 1 |
| Goncharenko, NV; Pankrat'ev, DV; Talalaenko, AN | 1 |
| Hedon, F | 1 |
| FELDMANN, H | 1 |
| Crow, TJ; Ferrier, IN; Johnstone, EC | 1 |
| Dettling, M; Dufeu, P; Gräf, K; Heinz, A; Kuhn, S; Kürten, I; Rommelspacher, H; Schmidt, LG | 1 |
| Abbate, F; Broersen, LM; de Bruin, JP; Feenstra, MG; Heinsbroek, RP; Olivier, B | 1 |
| Gordienko, DV; Krivobok, GK; Pankrat'ev, DV; Talalaenko, AN; Zinkovich, II | 1 |
| Gratton, A; Sullivan, RM | 1 |
| Cooper, T; DeCaria, CM; Hollander, E; Klein, DF; Nunes, E; Quitkin, FM; Wager, S | 1 |
| File, SE; Johnston, AL | 1 |
| Carlsson, A; Engel, JA; Hjorth, S | 1 |
| Amitai, M; Dickhaut, HH; Hasenknopf, P | 1 |
2 review(s) available for apomorphine and Anxiety
| Article | Year |
|---|---|
Future Targets for Female Sexual Dysfunction.
Topics: Alprostadil; Anxiety; Aphrodisiacs; Apomorphine; Consensus; Dehydroepiandrosterone; Dopamine; Dopamine Agonists; Dopamine Uptake Inhibitors; Evidence-Based Medicine; Female; Forecasting; Humans; Melanocortins; Neurotransmitter Agents; Nitric Oxide Donors; Pelvic Pain; Pharmacogenomic Testing; Phosphodiesterase 5 Inhibitors; Psychotherapy; Serotonin; Sexual Behavior; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Testosterone; Transcranial Magnetic Stimulation | 2016 |
Anxiety and erectile dysfunction: a global approach to ED enhances results and quality of life.
Topics: Anxiety; Apomorphine; Dopamine Agonists; Erectile Dysfunction; Humans; Male; Psychotherapy; Quality of Life | 2003 |
1 trial(s) available for apomorphine and Anxiety
| Article | Year |
|---|---|
Clinical effects of apomorphine in schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Anxiety; Apomorphine; Blinking; Chronic Disease; Clinical Trials as Topic; Humans; Male; Middle Aged; Schizophrenia | 1984 |
25 other study(ies) available for apomorphine and Anxiety
| Article | Year |
|---|---|
The elevated gradient of aversion: a new apparatus to study the rat behavior dimensions of anxiety, fear, and impulsivity.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Apomorphine; Behavior, Animal; Behavioral Research; Chlordiazepoxide; Dopamine Agonists; Exploratory Behavior; Fear; GABA Antagonists; Impulsive Behavior; Male; Maze Learning; Models, Animal; Pentylenetetrazole; Rats, Wistar; Time Factors | 2019 |
Involvement of prelimbic 5-HT
Topics: Animals; Anxiety; Apomorphine; Desipramine; Disease Models, Animal; Dopamine Agents; Enzyme Inhibitors; Exploratory Behavior; Functional Laterality; Male; Maze Learning; Oxidopamine; Parkinsonian Disorders; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Agents; Sympatholytics | 2018 |
Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats.
Topics: Animals; Anxiety; Apomorphine; Arachidonic Acids; Bicuculline; Cannabinoid Receptor Agonists; Disease Models, Animal; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; GABA-A Receptor Antagonists; Male; Maze Learning; Nitric Oxide Synthase; Oxadiazoles; Periaqueductal Gray; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Quinoxalines; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1 | 2013 |
Neurobehavioural evaluation of resveratrol in murine models of anxiety and schizophrenia.
Topics: Animals; Antioxidants; Antipsychotic Agents; Anxiety; Apomorphine; Behavior, Animal; Caloric Restriction; Exploratory Behavior; Female; Grooming; Male; Mice; Resveratrol; Schizophrenia; Schizophrenic Psychology; Stereotyped Behavior; Stilbenes; Swimming | 2017 |
Wfs1-deficient mice display impaired behavioural adaptation in stressful environment.
Topics: Adaptation, Psychological; Amphetamine; Animals; Anxiety; Apomorphine; Central Nervous System Stimulants; Conditioning, Classical; Corticosterone; Diazepam; Dopamine Agonists; Exploratory Behavior; Fear; Female; GABA Modulators; Genotype; Maze Learning; Membrane Proteins; Memory; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Polymerase Chain Reaction; Stress, Physiological | 2009 |
Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment.
Topics: Aging; Animals; Anxiety; Apomorphine; Behavior, Animal; Benzoxazines; Brain; Cannabinoids; Dopamine Agents; Haloperidol; Maze Learning; Morpholines; Motor Activity; Naphthalenes; Neurons; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Reflex, Startle | 2009 |
Ampullosporin A, a peptaibol from Sepedonium ampullosporum HKI-0053 with neuroleptic-like activity.
Topics: Animals; Antipsychotic Agents; Anxiety; Apomorphine; Avoidance Learning; Body Temperature; Brain; Catalepsy; Dizocilpine Maleate; Dopamine; Glutamic Acid; Hyperkinesis; Male; Motor Activity; Peptaibols; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Rotarod Performance Test; Social Behavior | 2009 |
Effects of morphine on rat behaviour in the elevated plus maze: the role of central amygdala dopamine receptors.
Topics: Amygdala; Animals; Anxiety; Apomorphine; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Exploratory Behavior; Male; Maze Learning; Morphine; Narcotics; Random Allocation; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 2009 |
Central nervous system effects of the essential oil of the leaves of Alpinia zerumbet in mice.
Topics: Alpinia; Animals; Antipsychotic Agents; Anxiety; Apomorphine; Behavior, Animal; Catalepsy; Central Nervous System; Central Nervous System Depressants; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Maze Learning; Mice; Motor Activity; Oils, Volatile; Plant Extracts; Tail | 2009 |
The effects of dopaminergic drugs in the ventral hippocampus of rats in the nicotine-induced anxiogenic-like response.
Topics: Animals; Anxiety; Apomorphine; Benzazepines; Dopamine Agents; Dopamine D2 Receptor Antagonists; Hippocampus; Male; Maze Learning; Motor Activity; Nicotine; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 2010 |
Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems.
Topics: Amygdala; Animals; Anti-Anxiety Agents; Anxiety; Apomorphine; Arachidonic Acids; Benzazepines; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Hippocampus; Male; Motor Activity; Random Allocation; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 2011 |
Effect of magnesium chloride on psychomotor activity, emotional status, and acute behavioural responses to clonidine, d-amphetamine, arecoline, nicotine, apomorphine, and L-5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Amphetamine; Animals; Anxiety; Apomorphine; Arecoline; Clonidine; Depression; Diet; Dietary Supplements; Emotions; Magnesium; Magnesium Chloride; Magnesium Deficiency; Male; Neurotransmitter Agents; Nicotine; Psychomotor Performance; Rats; Rats, Wistar; Stereotyped Behavior; Vitamin B 6 | 2011 |
Sublingual apomorphine as a neuroendocrine probe.
Topics: Administration, Sublingual; Adult; Anxiety; Apomorphine; Biomarkers; Depression; Dopamine Agonists; Growth Hormone; Humans; Male; Neurosecretory Systems; Prolactin; Self Report; Time Factors | 2012 |
Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Anxiety; Apomorphine; Benzazepines; Conditioning, Operant; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Male; Morphine; Nucleus Accumbens; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Reflex, Startle; Substance Withdrawal Syndrome | 2012 |
Deficient prepulse inhibition of acoustic startle in Hooded-Wistar rats compared with Sprague-Dawley rats.
Topics: Acoustic Stimulation; Amphetamine; Animals; Anxiety; Apomorphine; Disease Models, Animal; Dizocilpine Maleate; Dopamine Agonists; Excitatory Amino Acid Antagonists; Male; Maze Learning; Motor Activity; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reflex, Startle; Schizophrenia; Species Specificity | 2003 |
Neurochemical characteristics of the ventromedial hypothalamus in mediating the antiaversive effects of anxiolytics in different models of anxiety.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Apomorphine; Avoidance Learning; Biguanides; Brain Chemistry; Chlordiazepoxide; Clonidine; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Droperidol; Drug Interactions; GABA Agents; GABA Antagonists; GABA Modulators; gamma-Aminobutyric Acid; Glutamic Acid; Male; Memantine; Mephenytoin; Microinjections; Pentylenetetrazole; Phentolamine; Picrotoxin; Piperazines; Propranolol; Pyrimidines; Rats; Serotonin; Sulpiride; Ventromedial Hypothalamic Nucleus; Yohimbine | 2003 |
[Treatment of anxiety with apomorphine; application and clinical results].
Topics: Anxiety; Anxiety Disorders; Apomorphine; Humans | 1953 |
Psychopathological and behavioral correlates of dopaminergic sensitivity in alcohol-dependent patients.
Topics: Adult; Alcoholism; Anxiety; Apomorphine; Depression; Exploratory Behavior; Female; Human Growth Hormone; Humans; Male; Middle Aged; Receptors, Dopamine; Treatment Outcome | 1996 |
Prefrontal dopamine is directly involved in the anxiogenic interoceptive cue of pentylenetetrazol but not in the interoceptive cue of chlordiazepoxide in the rat.
Topics: Animals; Anxiety; Apomorphine; Chlordiazepoxide; Cues; Discrimination Learning; Dopamine; Dopamine Agonists; GABA Antagonists; GABA Modulators; Male; Pentylenetetrazole; Prefrontal Cortex; Rats; Rats, Wistar | 2000 |
The role of neurochemical mechanisms of ventromedial hypothalamus in various models of anxiety in rats.
Topics: Adrenergic Agents; Animals; Anxiety; Apomorphine; Avoidance Learning; Disease Models, Animal; Dopamine; Dopamine Agents; GABA Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Hypothalamus, Middle; Male; Memantine; Microinjections; Neurotransmitter Agents; Phenylephrine; Picrotoxin; Rats; Serotonin; Sulpiride; Yohimbine | 2001 |
Behavioral effects of excitotoxic lesions of ventral medial prefrontal cortex in the rat are hemisphere-dependent.
Topics: Animals; Anxiety; Apomorphine; Avoidance Learning; Behavior, Animal; Carbohydrates; Denervation; Dopamine Agonists; Excitatory Amino Acid Agonists; Functional Laterality; Ibotenic Acid; Male; Maze Learning; Milk; Motor Activity; Prefrontal Cortex; Quinine; Rats; Rats, Long-Evans; Reflex, Startle; Stress, Physiological; Taste | 2002 |
Dopaminergic sensitivity and cocaine abuse: response to apomorphine.
Topics: Adult; Anxiety; Apomorphine; Attention; Brain; Cocaine; Dopamine; Homovanillic Acid; Humans; Male; Prolactin; Receptors, Dopamine; Substance Withdrawal Syndrome; Substance-Related Disorders | 1990 |
Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic alpha-Agonists; Animals; Anxiety; Apomorphine; Azepines; Benzazepines; Clonidine; Dopamine Agents; Ergolines; Guanfacine; Guanidines; Learning; Male; Norepinephrine; Phenylacetates; Phenylephrine; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Dopamine; Yohimbine | 1989 |
Anticonflict effects of low doses of the dopamine agonist apomorphine in the rat.
Topics: Animals; Anxiety; Apomorphine; Conflict, Psychological; Dose-Response Relationship, Drug; Male; Muscle Tonus; Pain; Rats; Rats, Inbred Strains; Sensory Thresholds; Synaptic Transmission | 1986 |
[Therapy of withdrawal symptoms in "fixers". (Drug abuse of adolescents by intravenous injection)].
Topics: Adolescent; Adult; Anxiety; Apomorphine; Female; Hallucinations; Humans; Male; Morphine Dependence; Psychotherapy; Substance Withdrawal Syndrome | 1972 |